JP5820096B2 - Aqueous composition - Google Patents
Aqueous composition Download PDFInfo
- Publication number
- JP5820096B2 JP5820096B2 JP2009177170A JP2009177170A JP5820096B2 JP 5820096 B2 JP5820096 B2 JP 5820096B2 JP 2009177170 A JP2009177170 A JP 2009177170A JP 2009177170 A JP2009177170 A JP 2009177170A JP 5820096 B2 JP5820096 B2 JP 5820096B2
- Authority
- JP
- Japan
- Prior art keywords
- aqueous composition
- der
- general formula
- agent
- anionic compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 41
- -1 polyoxyethylene Polymers 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 27
- 239000003242 anti bacterial agent Substances 0.000 claims description 18
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 150000001449 anionic compounds Chemical class 0.000 claims description 13
- 239000002537 cosmetic Substances 0.000 claims description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- 150000005215 alkyl ethers Chemical class 0.000 claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims description 7
- 239000002324 mouth wash Substances 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 239000002738 chelating agent Substances 0.000 claims description 5
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims description 5
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 4
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 4
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229940051866 mouthwash Drugs 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 239000003599 detergent Substances 0.000 claims description 3
- 238000004851 dishwashing Methods 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000000551 dentifrice Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 description 17
- 229920002413 Polyhexanide Polymers 0.000 description 16
- 239000007864 aqueous solution Substances 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 7
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 229920001090 Polyaminopropyl biguanide Polymers 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 229940093424 polyaminopropyl biguanide Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229960004106 citric acid Drugs 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229940093158 polyhexanide Drugs 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
Description
本発明は水系組成物、例えば水系パーソナルケア製品である化粧品類、薬用化粧品類、洗口液、液体歯磨きなど、水系家庭用品である衣類用洗剤、衣類用柔軟剤、食器洗浄剤、風呂用洗浄剤、トイレ用洗浄剤、抗菌スプレーなどに関し、ポリカチオン型抗菌剤および多価アニオン性化合物を含有する水系組成物に関するものである。 The present invention relates to water-based compositions, for example, water-based personal care products such as cosmetics, medicated cosmetics, mouthwashes, liquid toothpaste, and other water-based household products such as clothes detergents, clothes softeners, dishwashing agents, and bath washings. The present invention relates to a water-based composition containing a polycation type antibacterial agent and a polyvalent anionic compound, such as an agent, a toilet cleaning agent and an antibacterial spray.
本発明の水系組成物中、ポリカチオン型抗菌剤は組成物の細菌、真菌などの微生物に起因する製品の変質、腐敗を防止するための防腐剤として、また組成物に抗菌性を付与することにより皮膚上や口腔中の細菌、真菌などの微生物による障害の予防や治療、処理した衣類や器物上の微生物除去、また処理面に抗菌性や防臭性を付与するために配合される。 In the aqueous composition of the present invention, the polycation type antibacterial agent is used as a preservative for preventing deterioration or decay of products caused by microorganisms such as bacteria and fungi in the composition, and imparting antibacterial properties to the composition. Is added to prevent or treat disorders caused by microorganisms such as bacteria and fungi in the skin and oral cavity, remove microorganisms on treated clothing and equipment, and impart antibacterial and deodorant properties to the treated surface.
従来からポリカチオン型抗菌剤は種々ある抗菌剤のひとつとして水系製品の多くの分野で用いられている。 Conventionally, polycation type antibacterial agents are used in many fields of water-based products as one of various antibacterial agents.
例えば防腐目的に化粧品類に配合される抗菌剤としては本邦薬事法での化粧基準の別表3、欧州化粧品指令別添6や米国香粧品業界CTFAによるInternational Cosmetic Ingredient Dictionary and Handbookなどに配合可能な成分が収載されている。 For example, as antibacterial agents blended into cosmetics for antiseptic purposes, ingredients that can be blended in Appendix 3 of Cosmetic Standards under the Japanese Pharmaceutical Affairs Law, European Cosmetic Directive Attachment 6 and International Cosmetic Ingredient Dictionary and Handbook by the US Cosmetic Industry CTFA Is listed.
組成物に抗菌性を付与するものとしては塩化ベンザルコニウムや塩化セチルピリジニウムを代表とする4級アンモニウム塩類、トリクロサンやイソプロピルメチルフェノールを代表とするフェノール類、グルコン酸クロルヘキシジンやポリヘキサメチレンビグアナイド塩酸塩を代表とするビグアナイド系化合物などが用いられ、手洗い石鹸、洗口液、ニキビ用洗顔料、抗菌効果を謳う繊維用柔軟剤など幅広い分野で応用が行われている。 Antibacterial properties are imparted to the composition by quaternary ammonium salts such as benzalkonium chloride and cetylpyridinium chloride, phenols such as triclosan and isopropylmethylphenol, chlorhexidine gluconate and polyhexamethylene biguanide hydrochloride. Biguanide-based compounds such as those used in hand washing soaps, mouthwashes, acne facial cleansers, fiber softeners that have an antibacterial effect, and are applied in a wide range of fields.
水系組成物には汎用で多価アニオン性化合物が配合される。例えばガム類やポリアクリル酸誘導体は組成物の粘度調整に、クエン酸及びその塩やEDTA及びその塩はキレート剤やpH調整剤として、グリチルリチン酸及びその塩やヒアルロン酸及びその塩やポリリン酸類及びその塩などがパーソナルケア製品等での訴求効果のために配合される。 The water-based composition contains a general-purpose polyvalent anionic compound. For example, gums and polyacrylic acid derivatives are used to adjust the viscosity of the composition, citric acid and salts thereof and EDTA and salts thereof as chelating agents and pH adjusters, glycyrrhizic acid and salts thereof, hyaluronic acid and salts thereof, and polyphosphoric acids and The salt and the like are blended for appealing effects in personal care products.
しかしながら水系組成物においてはその成分の組み合わせにより著しい白濁や沈殿を生じるという問題があり、透明外観を損ない、また品質保証に問題を生じる。水系組成物にポリカチオン型抗菌剤を多価アニオン性化合物とともに配合する場合、両者間での静電的作用により白濁を生じ、または沈殿が生じるためにその解決方法は有用である。 However, in the aqueous composition, there is a problem that significant cloudiness or precipitation occurs due to the combination of the components, which impairs the transparent appearance and causes a problem in quality assurance. In the case where a polycation type antibacterial agent is blended with a polyvalent anionic compound in an aqueous composition, the solution is useful because white turbidity or precipitation occurs due to electrostatic action between the two.
本発明者らは水系組成物においてポリオキシエチレンアルキルエーテル及び/またはポリエチレングリコール脂肪酸エステルを配合することにより、多価アニオン性化合物およびポリカチオン型抗菌剤をともに配合した場合においても著しい白濁や沈殿の発生が防止されることを見出した。すなわち、本発明は、ポリカチオン型抗菌剤、一般式(1)で表されるポリオキシエチレンアルキルエーテル及び/または一般式(2)で表わされるポリエチレングリコール脂肪酸エステル、多価アニオン性化合物、及び水を含有することを特徴とする水系組成物、
(式中、R1は飽和または不飽和アルキル基である)
(式中、R2は飽和または不飽和アルキル基である)を提供する。
The present inventors blended polyoxyethylene alkyl ether and / or polyethylene glycol fatty acid ester in an aqueous composition, so that even when both a polyvalent anionic compound and a polycation type antibacterial agent were blended, significant cloudiness and precipitation were observed. It was found that the occurrence was prevented. That is, the present invention relates to a polycationic antibacterial agent, a polyoxyethylene alkyl ether represented by the general formula (1) and / or a polyethylene glycol fatty acid ester represented by the general formula (2), a polyvalent anionic compound, and water. An aqueous composition comprising:
(Wherein R 1 is a saturated or unsaturated alkyl group)
Wherein R 2 is a saturated or unsaturated alkyl group.
本発明に用いられるポリカチオン型抗菌剤は水に溶解すると電離して2以上の正電荷を有する有機化合物であり、例えばグルコン酸クロルヘキジン、塩酸クロルヘキシジン、ポリヘキサメチレングアニジン塩酸塩、ポリヘキサメチレングアニジンリン酸塩、ポリヘキサメチレンビグアナイド塩酸塩、ポリヘキサメチレンビグアナイドステアリン酸塩、ポリ[オキシエチレン(ジメチルイミニオ)エチレン(ジメチルイミニオ)エチレンジクロリド]が挙げられる。特にポリヘキサメチレンビグアナイド塩は水溶性が高い一方、皮膚刺激が非常に低いことから水系のパーソナルケア製品や水系の家庭用品により好適な材料である。 The polycationic antibacterial agent used in the present invention is an organic compound that is ionized when dissolved in water and has two or more positive charges. For example, chlorhexidine gluconate, chlorhexidine hydrochloride, polyhexamethyleneguanidine hydrochloride, polyhexamethyleneguanidine phosphorus Acid salt, polyhexamethylene biguanide hydrochloride, polyhexamethylene biguanide stearate, poly [oxyethylene (dimethyliminio) ethylene (dimethyliminio) ethylene dichloride]. In particular, polyhexamethylene biguanide salt is highly suitable for water-based personal care products and water-based household products because it has high water solubility and very low skin irritation.
ポリヘキサメチレンビグアナイド塩はアーチ・ケミカルズ社より、VANTOCIL IB、VANTOCIL TG、VANTOCIL P、PROXEL IBの製品名でその塩酸塩の20%水溶液が市販されている。ポリヘキサメチレンビグアナイドの別称としてポリアミノプロピルビグアナイド(香粧品類でのINCI名称)、ポリヘキサニド(医薬品類でのINN名称)があり、アーチ・ケミカルズ社よりCOSMOCIL CQ、COSMOCIL PGの製品名で塩酸塩の20%水溶液が市販されている。ポリヘキサメチレンビグアナイドには塩酸塩の他にステアリン酸塩が知られている。 Polyhexamethylene biguanide salt is commercially available from Arch Chemicals under the product names of VANTOCIL IB, VANTOCIL TG, VANTOCIL P, and PROXEL IB. Other names for polyhexamethylene biguanide include polyaminopropyl biguanide (INCI name in cosmetics) and polyhexanide (INN name in pharmaceuticals). % Aqueous solution is commercially available. In addition to hydrochloride, stearate is known as polyhexamethylene biguanide.
本発明の水系組成物に用いられる多価アニオン性化合物は水に溶解すると電離して2価以上の負電荷を有する有機化合物または無機化合物であり、例えばガム類やポリアクリル酸誘導体は組成物の粘度調整に、クエン酸及びその塩やEDTA及びその塩はキレート剤やpH調整剤として、グリチルリチン酸及びその塩やヒアルロン酸及びその塩やポリリン酸類及びその塩などがパーソナルケア製品等での訴求効果のために配合される。 The polyvalent anionic compound used in the aqueous composition of the present invention is an organic compound or an inorganic compound that is ionized when dissolved in water and has a negative charge of 2 or more. For example, gums and polyacrylic acid derivatives are used in the composition. Citric acid and its salts, EDTA and its salts are used as chelating agents and pH adjusters for viscosity adjustment, and glycyrrhizic acid and its salts, hyaluronic acid and its salts, polyphosphoric acids and its salts are appealing effects in personal care products, etc. Formulated for.
グリチルリチン酸、及びその塩はその抗炎作用や抗アレルギー作用から化粧水、美容液、洗顔料などの化粧品類、薬用化粧品類、洗口液などに配合される。また甘味料として各種口腔用途の水系製品の味覚改良のために配合される。 Glycyrrhizic acid and its salts are blended in cosmetics such as lotion, cosmetic liquid and face wash, medicinal cosmetics, mouthwash and the like because of its anti-inflammatory and anti-allergic effects. It is also added as a sweetener to improve the taste of water-based products for various oral uses.
キレート剤は、洗浄剤において重金属イオンのマスキングや泡安定化による洗浄性の向上成分としてや、各種水系製品のpH調整剤として配合される。例えば、クエン酸及びその塩類、エチレンジアミン四酢酸及びその塩類、エチドロン酸及びその塩類、リンゴ酸及びその塩類、ニトリロ三酢酸及びその塩類、グルタミン酸二酢酸及びその塩類、エチレンジアミンヒドロキシエチル三酢酸及びその塩類、酒石酸及びその塩類、ポリリン酸及びその塩類、トリポリリン酸及びその塩類、メタリン酸及びその塩類が用いられる。これらの内、クエン酸及びその塩類は安全性が高く、水溶性が高く、また酸と塩類の組み合わせにより組成物のpHを弱酸性〜弱アルカリ性に容易に調整できることから幅広い水系のパーソナルケア製品や水系の家庭用品類に配合される。 The chelating agent is blended as a component for improving the detergency by masking heavy metal ions or stabilizing the foam in the detergent or as a pH adjuster for various aqueous products. For example, citric acid and its salts, ethylenediaminetetraacetic acid and its salts, etidronic acid and its salts, malic acid and its salts, nitrilotriacetic acid and its salts, glutamic acid diacetic acid and its salts, ethylenediaminehydroxyethyl triacetic acid and its salts, Tartaric acid and its salts, polyphosphoric acid and its salts, tripolyphosphoric acid and its salts, metaphosphoric acid and its salts are used. Among these, citric acid and its salts are highly safe, highly water-soluble, and the pH of the composition can be easily adjusted from weak acidity to weak alkalinity by a combination of acids and salts, so a wide range of water-based personal care products and Used in water-based household products.
本発明の水系組成物に用いられる一般式(1)で表わされるポリオキシエチレンアルキルエーテルは加水分解性が低く、水系組成物の高温での調合時においても、また幅広いpHの製品で使用可能であることが特長である。R1の炭素数が単一のものと分布をもつもの、R1が直鎖のものと分岐のもの、R1が飽和アルキルのものと不飽和アルキルのものなどの種類がある。エチレンオキサイドの繰り返し数nは2以上100程度までのものが汎用され、分子量分布が割合に広いものから、分子量分布のない単一繰り返し数のものがある。R1の種類とエチレンオキサイドの繰り返し数nの組み合わせにより、幅広いHLB値(親水性/親油性バランス)のものが選択可能で顔料の分散、香料やオイルなどの油性成分の水相への可溶化などに用いられている。このうち、R1の炭素数が12以上で、直鎖、HLB値が18.0以上のものが本発明の水系組成物により好適である。R1の炭素数は好ましくは24以下である。エチレンオキサイドの繰り返し数nは、好ましくは2〜200である。 The polyoxyethylene alkyl ether represented by the general formula (1) used in the aqueous composition of the present invention has low hydrolyzability, and can be used in products having a wide pH range even when the aqueous composition is formulated at a high temperature. It is a feature. Which carbon number of R 1 has a distribution as a single, one R 1 is a branch to that of linear, R 1 is the type such as those ones and unsaturated alkyl, saturated alkyl. The number of ethylene oxide repeats n is generally in the range of 2 to 100, and there are those having a single molecular number distribution with no molecular weight distribution from those having a relatively wide molecular weight distribution. A wide range of HLB values (hydrophilic / lipophilic balance) can be selected depending on the combination of the type of R 1 and the number of ethylene oxide repetitions n. Dispersion of pigments and solubilization of oily components such as perfumes and oils in the aqueous phase It is used for etc. Among these, R 1 having 12 or more carbon atoms, straight chain, and HLB value of 18.0 or more is more preferable for the aqueous composition of the present invention. R 1 preferably has 24 or less carbon atoms. The repeating number n of ethylene oxide is preferably 2 to 200.
(R1及びnは上記のとおりである)
(R 1 and n are as described above)
例えば、表1のポリオキシエチレンアルキルエーテルが使用可能である。 For example, the polyoxyethylene alkyl ethers in Table 1 can be used.
本発明の水系組成物に用いられる一般式(2)で表わされるポリエチレングリコール脂肪酸エステルは安全性が高く、水系組成物の高温での調合時においても、また幅広いpHの製品で使用可能であることが特長である。エチレンオキサイドの繰り返し数mは2以上150程度までのものが汎用され、R2の種類とエチレンオキサイドの繰り返し数mの組み合わせにより、幅広いHLB値(親水性/親油性バランス)のものが選択可能で顔料の分散、香料やオイルなどの油性成分の水相への可溶化などに用いられている。このうち、R2の炭素数が11以上で、直鎖、HLB値が18.0以上のものが本発明の水系組成物により好適である。R2の炭素数は好ましくは23以下である。エチレンオキサイドの繰り返し数mは、好ましくは2〜200である。 The polyethylene glycol fatty acid ester represented by the general formula (2) used in the aqueous composition of the present invention is highly safe and can be used in products having a wide pH range even when the aqueous composition is formulated at a high temperature. Is a feature. The number of ethylene oxide repeats m is generally in the range of 2 to 150, and a wide range of HLB values (hydrophilic / lipophilic balance) can be selected depending on the combination of R 2 type and ethylene oxide repeat number m. It is used to disperse pigments and solubilize oily components such as perfumes and oils in the aqueous phase. Among these, those having a carbon number of R 2 of 11 or more, linear, and HLB value of 18.0 or more are more suitable for the aqueous composition of the present invention. R 2 preferably has 23 or less carbon atoms. The repeating number m of ethylene oxide is preferably 2 to 200.
(R2及びmは上記のとおりである)
(R 2 and m are as described above)
例えば、表2のポリエチレングリコール脂肪酸エステルが使用可能である。 For example, the polyethylene glycol fatty acid esters in Table 2 can be used.
本発明の水系組成物には必要に応じて、例えば香料の可溶化剤としてや肌への感触向上剤としてや洗浄剤などとしてポリオキシエチレンアルキルエーテル、ポリエチレングリコール脂肪酸エステル以外の界面活性剤を添加することができる。 If necessary, surfactants other than polyoxyethylene alkyl ether and polyethylene glycol fatty acid ester are added to the aqueous composition of the present invention, for example, as a solubilizing agent for fragrances, as a skin feel improver or as a cleaning agent. can do.
本発明の水系組成物には必要に応じて、例えば増粘剤、香料、甘味料、染料、顔料、UV吸収剤、溶剤、油剤、抗炎症剤、収斂剤、酸化防止剤、ポリカチオン型抗菌剤以外の抗菌剤、多価アニオン性化合物以外のpH調整剤などを添加してもよい。 If necessary, the aqueous composition of the present invention includes, for example, a thickener, a fragrance, a sweetener, a dye, a pigment, a UV absorber, a solvent, an oil, an anti-inflammatory agent, an astringent, an antioxidant, a polycation type antibacterial agent. You may add antibacterial agents other than an agent, pH adjusters other than a polyvalent anionic compound, and the like.
本発明の水系組成物は香粧品や家庭用品の製造での定法で調合可能であるが、多価アニオン性化合物とポリオキシエチレンアルキルエーテル及び/またはポリエチレングリコール脂肪酸エステルを含む液を予め調合し、これにポリカチオン型抗菌剤を添加する手順がより好ましい。 The aqueous composition of the present invention can be prepared by a conventional method in the production of cosmetics and household products, but a liquid containing a polyvalent anionic compound and polyoxyethylene alkyl ether and / or polyethylene glycol fatty acid ester is prepared in advance. The procedure of adding a polycation type antibacterial agent to this is more preferable.
本発明の水系組成物中のポリカチオン型抗菌剤の濃度は組成物の防腐の目的には好ましくは0.001重量%から0.3重量%、より好ましくは0.005重量%から0.1重量%の濃度で配合される。組成物に抗菌性を付加する目的には好ましくは0.01重量%から0.5重量%、より好ましくは0.02重量%から0.3重量%の濃度で配合される。 The concentration of the polycationic antibacterial agent in the aqueous composition of the present invention is preferably 0.001 to 0.3% by weight, more preferably 0.005 to 0.1% by weight for the purpose of preserving the composition. Formulated in a concentration by weight. For the purpose of adding antibacterial properties to the composition, it is preferably blended at a concentration of 0.01 wt% to 0.5 wt%, more preferably 0.02 wt% to 0.3 wt%.
本発明の水系組成物中の多価アニオン性化合物は好ましくは0.001重量%から0.5重量%の範囲で配合される。 The polyvalent anionic compound in the aqueous composition of the present invention is preferably blended in the range of 0.001 wt% to 0.5 wt%.
本発明の水系組成物中のポリオキシエチレンアルキルエーテル及び/またはポリエチレングリコール脂肪酸エステルは、好ましくはポリカチオン型抗菌剤の濃度に対して2倍以上の濃度で配合される。より好ましくは、ポリカチオン型抗菌剤の濃度に対するポリオキシエチレンアルキルエーテル及び/またはポリエチレングリコール脂肪酸エステルの濃度は4,000倍以下、より好ましくは2,000倍以下である。 The polyoxyethylene alkyl ether and / or polyethylene glycol fatty acid ester in the aqueous composition of the present invention is preferably blended at a concentration of 2 times or more with respect to the concentration of the polycation type antibacterial agent. More preferably, the concentration of the polyoxyethylene alkyl ether and / or polyethylene glycol fatty acid ester with respect to the concentration of the polycationic antibacterial agent is 4,000 times or less, more preferably 2,000 times or less.
以下、実施例、比較例により本発明を具体的に説明するが、本発明はこれらの例によって制限されるものではない。実施例、比較例中の「%」は「重量%」を表す。 EXAMPLES Hereinafter, although an Example and a comparative example demonstrate this invention concretely, this invention is not restrict | limited by these examples. “%” In Examples and Comparative Examples represents “% by weight”.
(実施例1)
10%のポリオキシエチレンアルキルエーテル、またはポリエチレングリコール脂肪酸エステル(界面活性剤)の精製水溶液を調製した。リン酸一カリウム(KH2PO4)0.24%、リン酸二ナトリウム(Na2HPO4)0.36%、グリチルリチン酸ジカリウム0.05%、所定濃度となるようポリオキシエチレンアルキルエーテル、またはポリエチレングリコール脂肪酸エステルの10%精製水溶液を加えた精製水溶液を50mL調製した。スターラーで撹拌しながら、これにポリヘキサメチレンビグアナイド塩酸塩の2%水溶液を1.25g滴下した(ポリヘキサメチレンビグアナイド塩酸塩0.05%)。混合後の溶液の外観を観察した。結果を表3に示した。
Example 1
A purified aqueous solution of 10% polyoxyethylene alkyl ether or polyethylene glycol fatty acid ester (surfactant) was prepared. Monopotassium phosphate (KH 2 PO 4 ) 0.24%, disodium phosphate (Na 2 HPO 4 ) 0.36%, dipotassium glycyrrhizinate 0.05%, polyoxyethylene alkyl ether to a predetermined concentration, or 50 mL of a purified aqueous solution to which a 10% purified aqueous solution of polyethylene glycol fatty acid ester was added was prepared. While stirring with a stirrer, 1.25 g of a 2% aqueous solution of polyhexamethylene biguanide hydrochloride was added dropwise thereto (0.05% polyhexamethylene biguanide hydrochloride). The appearance of the solution after mixing was observed. The results are shown in Table 3.
(比較例1)
界面活性剤を表4に示したものに変更した以外は実施例1と同一の精製水溶液を50mL調製した。スターラーで撹拌しながら、これにポリヘキサメチレンビグアナイド塩酸塩の2%水溶液を1.25g滴下した(ポリヘキサメチレンビグアナイド塩酸塩0.05%)。混合後の溶液の外観を観察した。結果を表4に示した。
(Comparative Example 1)
50 mL of the same purified aqueous solution as in Example 1 was prepared except that the surfactant was changed to that shown in Table 4. While stirring with a stirrer, 1.25 g of a 2% aqueous solution of polyhexamethylene biguanide hydrochloride was added dropwise thereto (0.05% polyhexamethylene biguanide hydrochloride). The appearance of the solution after mixing was observed. The results are shown in Table 4.
(実施例2)
界面活性剤を表5に示したものに変更した以外は実施例1と同一の精製水溶液を50mL調製した。スターラーで撹拌しながら、これにポリヘキサメチレンビグアナイド塩酸塩の2%水溶液を0.5g滴下した(ポリヘキサメチレンビグアナイド塩酸塩0.02%)。混合後の溶液の外観を観察した。結果を表5に示した。
(Example 2)
50 mL of the same purified aqueous solution as in Example 1 was prepared except that the surfactant was changed to that shown in Table 5. While stirring with a stirrer, 0.5 g of a 2% aqueous solution of polyhexamethylene biguanide hydrochloride was added dropwise thereto (polyhexamethylene biguanide hydrochloride 0.02%). The appearance of the solution after mixing was observed. The results are shown in Table 5.
(実施例3)
クエン酸3ナトリウム2水和物0.15%、無水クエン酸0.05g、表6に記載の界面活性剤を所定濃度含んだ精製水溶液を50mL調製した。スターラーで撹拌しながら、これにポリヘキサメチレンビグアナイド塩酸塩の2%水溶液を0.5g滴下した(ポリヘキサメチレンビグアナイド塩酸塩0.02%)。混合後の溶液の外観を観察した。結果を表6に示した。
(Example 3)
50 mL of a purified aqueous solution containing trisodium citrate dihydrate 0.15%, anhydrous citric acid 0.05 g, and the surfactants listed in Table 6 at a predetermined concentration was prepared. While stirring with a stirrer, 0.5 g of a 2% aqueous solution of polyhexamethylene biguanide hydrochloride was added dropwise thereto (polyhexamethylene biguanide hydrochloride 0.02%). The appearance of the solution after mixing was observed. The results are shown in Table 6.
(比較例2)
界面活性剤を表7に示したものに変更した以外は実施例3と同一の精製水溶液を50mL調製した。スターラーで撹拌しながら、これにポリヘキサメチレンビグアナイド塩酸塩の2%水溶液を0.5g滴下した(ポリヘキサメチレンビグアナイド塩酸塩0.02%)。混合後の溶液の外観を観察した。結果を表7に示した。
(Comparative Example 2)
50 mL of the same purified aqueous solution as in Example 3 was prepared except that the surfactant was changed to that shown in Table 7. While stirring with a stirrer, 0.5 g of a 2% aqueous solution of polyhexamethylene biguanide hydrochloride was added dropwise thereto (polyhexamethylene biguanide hydrochloride 0.02%). The appearance of the solution after mixing was observed. The results are shown in Table 7.
(実施例4 化粧水)
(*20%ポリアミノプロピルビグアナイド(アーチ・ケミカルズ社製))
(製法)A、Bを50℃で混合、Cを常温で混合する。撹拌しながらBをAに徐々に加える。更にCを滴下し撹拌を続けながら放冷し30〜35℃で撹拌を停止する。
(Example 4 lotion)
(* 20% polyaminopropyl biguanide (manufactured by Arch Chemicals))
(Manufacturing method) A and B are mixed at 50 degreeC, and C is mixed at normal temperature. Gradually add B to A with stirring. Further, C is added dropwise and the mixture is allowed to cool while stirring, and stirring is stopped at 30 to 35 ° C.
(比較例3 化粧水)
(*20%ポリアミノプロピルビグアナイド(アーチ・ケミカルズ社製))
(製法)A、Bを50℃で混合、Cを常温で混合する。撹拌しながらBをAに徐々に加える。更にCを滴下し撹拌を続けながら放冷し30〜35℃で撹拌を停止する。
(Comparative Example 3 lotion)
(* 20% polyaminopropyl biguanide (manufactured by Arch Chemicals))
(Manufacturing method) A and B are mixed at 50 degreeC, and C is mixed at normal temperature. Gradually add B to A with stirring. Further, C is added dropwise and the mixture is allowed to cool while stirring, and stirring is stopped at 30 to 35 ° C.
(実施例5 洗口液)
(*20%ポリアミノプロピルビグアナイド(アーチ・ケミカルズ社製))
(製法)Aを60℃で混合、B、Cは常温で混合する。撹拌しながらBをAに徐々に加える。更にCを滴下し撹拌を続けながら放冷し30〜35℃で撹拌を停止する。
(Example 5 mouthwash)
(* 20% polyaminopropyl biguanide (manufactured by Arch Chemicals))
(Manufacturing method) A is mixed at 60 ° C., and B and C are mixed at room temperature. Gradually add B to A with stirring. Further, C is added dropwise and the mixture is allowed to cool while stirring, and stirring is stopped at 30 to 35 ° C.
(比較例4 洗口液)
(*20%ポリアミノプロピルビグアナイド(アーチ・ケミカルズ社製))
(製法)Aを60℃で混合、B、Cは常温で混合する。撹拌しながらBをAに徐々に加える。更にCを滴下し撹拌を続けながら放冷し30〜35℃で撹拌を停止する。
(Comparative Example 4 Mouthwash)
(* 20% polyaminopropyl biguanide (manufactured by Arch Chemicals))
(Manufacturing method) A is mixed at 60 ° C., and B and C are mixed at room temperature. Gradually add B to A with stirring. Further, C is added dropwise and the mixture is allowed to cool while stirring, and stirring is stopped at 30 to 35 ° C.
実施例4および5と比較例3および4の調合時の外観と−3℃で1日間保管した場合の製剤の安定性を観察した。結果を表8に示した。 The appearance of the preparations of Examples 4 and 5 and Comparative Examples 3 and 4 and the stability of the preparations when stored at -3 ° C for 1 day were observed. The results are shown in Table 8.
本発明の水系組成物は多価アニオン性化合物およびポリカチオン型抗菌剤を成分として配合した場合においても著しい白濁や沈殿の発生が防止されている水系組成物を提供するものである。 The aqueous composition of the present invention provides an aqueous composition in which significant cloudiness and precipitation are prevented even when a polyvalent anionic compound and a polycationic antibacterial agent are blended as components.
Claims (4)
一般式(1)で表わされるポリオキシエチレンアルキルエーテル及び/または一般式(2)で表わされるポリエチレングリコール脂肪酸エステルのHLB値が18.0以上であり、その組成物中の濃度が0.125−1.0重量%であり、その配合量がポリカチオン抗菌剤の2倍以上(重量%に基づく)であることを特徴とする、化粧品、薬用化粧品、洗口液、液体歯磨き、衣類用洗剤、衣類用柔軟剤、食器洗浄剤、風呂用洗浄剤、トイレ用洗浄剤、または抗菌スプレー用水系組成物、
(式中、R1は炭素数11以上24以下であり、直鎖の飽和または不飽和アルキル基であり、nは2〜200である。)
(式中、R2は炭素数11以上23以下であり、直鎖の飽和または不飽和アルキル基であり、mは2〜200である。)。 A polycationic antibacterial agent which is a polyhexamethylene biguanide salt, a polyoxyethylene alkyl ether represented by the general formula (1) and / or a polyethylene glycol fatty acid ester represented by the general formula (2), a polyvalent anionic compound, and Contains water,
The HLB value of the polyoxyethylene alkyl ether represented by the general formula (1) and / or the polyethylene glycol fatty acid ester represented by the general formula (2) is 18.0 or more, and the concentration in the composition is 0.125- 1.0 wt% der is, the amount is 2 times or more than one polycationic antibacterial agent (based on weight percent), wherein der Rukoto, cosmetics, medicated cosmetics, mouthwash, liquid dentifrice, clothing Detergent, clothing softener, dishwashing agent, bath cleaner, toilet cleaner, or antibacterial spray aqueous composition,
(Wherein, R 1 is a number 11 or more 24 or less carbon atoms, Ri saturated or unsaturated alkyl group Der linear, n represents Ru 2 to 200 der.)
(Wherein, R 2 is a number 11 or more 23 or less carbon atoms, Ri saturated or unsaturated alkyl group der linear, m is Ru 2-200 der.).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009177170A JP5820096B2 (en) | 2009-07-30 | 2009-07-30 | Aqueous composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009177170A JP5820096B2 (en) | 2009-07-30 | 2009-07-30 | Aqueous composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011032306A JP2011032306A (en) | 2011-02-17 |
| JP5820096B2 true JP5820096B2 (en) | 2015-11-24 |
Family
ID=43761710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009177170A Expired - Fee Related JP5820096B2 (en) | 2009-07-30 | 2009-07-30 | Aqueous composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5820096B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6184825B2 (en) * | 2013-09-30 | 2017-08-23 | ユニ・チャーム株式会社 | Kit for preparing skin cleansing composition, skin cleansing composition, and method for preparing skin cleansing composition |
| JP6228005B2 (en) * | 2013-12-26 | 2017-11-08 | 花王株式会社 | Method for producing detergent composition for automatic dishwasher, and method for suppressing adhesion of solid particles to hydrophilic hard material |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4065591B2 (en) * | 1998-01-07 | 2008-03-26 | Hoyaヘルスケア株式会社 | Contact lens solution and contact lens cleaning method using the same |
| JPH11322515A (en) * | 1998-05-07 | 1999-11-24 | Menicon Co Ltd | Liquid for contact lens |
| JP4578776B2 (en) * | 2003-01-31 | 2010-11-10 | 花王株式会社 | Disinfectant cleaning composition |
| JP2006016491A (en) * | 2004-07-01 | 2006-01-19 | S T Chem Co Ltd | Detergent composition and method for cleaning |
| JP4781664B2 (en) * | 2004-11-17 | 2011-09-28 | 花王株式会社 | Antibacterial agent |
-
2009
- 2009-07-30 JP JP2009177170A patent/JP5820096B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011032306A (en) | 2011-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008300404B2 (en) | Formulations comprising an anti-microbial composition | |
| CN101254157B (en) | Preservative compositions | |
| CN1387426A (en) | Detergent composition | |
| DE10358534A1 (en) | Adhesion inhibition of microorganisms by nonionic surfactants | |
| DE102009001569A1 (en) | Lilial substitute | |
| WO1997048377A1 (en) | Skin wash compositions comprising triclocarban and surfactants | |
| JP7570122B2 (en) | Antiseptic, antibacterial and preservative compositions | |
| EP4572857A1 (en) | Transparent cosmetic and personal care compositions | |
| JPWO2011013494A1 (en) | Aqueous composition | |
| JP6184825B2 (en) | Kit for preparing skin cleansing composition, skin cleansing composition, and method for preparing skin cleansing composition | |
| CN104220042A (en) | Foaming formulations comprising silicone-based polyurethanes | |
| JP5820096B2 (en) | Aqueous composition | |
| DE102004028018A1 (en) | Use of substances that release terpenes and / or perfume alcohols, to inhibit the adhesion of microorganisms | |
| JPS6239698A (en) | Self-purifying cleansing preparation | |
| WO2008116768A1 (en) | Anti-mite product | |
| JP3472349B2 (en) | Antibacterial cleaning composition | |
| JP2006143620A (en) | Antibacterial agent | |
| JPH11152493A (en) | Composition containing amidoamine oxide compound excellent in stability of hue and perfume | |
| JPH11158489A (en) | Amidoamine oxide compound-containing irritation-relieving agent for surfactant | |
| EP4282944A1 (en) | Unit dose for personal care or household care composition | |
| JP2023146622A (en) | Method for producing liquid disinfectant composition | |
| DE2410132A1 (en) | ORAL AND / OR DENTAL CARE PRODUCTS | |
| CN121399236A (en) | Composition comprising biosurfactant and manganese | |
| WO2008007425A1 (en) | Preservative composition | |
| DE10350929A1 (en) | Use of dispirotripiperazine derivatives to treat fungal infections or to prevent adhesion of fungi to surfaces |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120531 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130719 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130823 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131018 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20140529 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140529 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140711 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141008 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20141201 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20150206 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150811 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151002 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5820096 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |